ShawSpring Partners led a $150m funding round in Ro.

ShawSpring Partners, a Boston-based investment firm, led a $150m funding round in Ro, a developer of a direct-to-consumer telehealth platform, with participation from General Catalyst, FirstMark Capital, TQ Ventures, SignalFire, BoxGroup, The Chernin Group, Initialized Capital, Altimeter Capital, Baupost Group, and Seven Seven Six. "In less than five years, Ro has become the only company to combine nationwide telemedicine, in-home care, diagnostics, labs, and pharmacy services. With this funding, Ro can accelerate our pursuit of revolutionizing healthcare by building accessible, impactful, and trusted care that people want. This year, that means debuting a unified, single-branded care experience for our patients and further enabling other healthcare companies to benefit from the patient-centric technology and services we've built," Zachariah Reitano, Ro Co-Founder & CEO.